Cytotoxicity evaluation of a new series of naphthalimide derivatives against human cancer cell lines

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALIABADI ALIREZA; MOHAMMADI FARANI AHMAD; Haqiqi Arash; Khanlari Elham

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Shahid Sadoughi University of Medical Sciences Year:2019 | Volume:26 | Issue:11 Page(s): 998-1007

Download Full-Text

Persian Verion

View:

573

Download:

Cites:

Information Journal Paper

Title

Cytotoxicity evaluation of a new series of naphthalimide derivatives against human cancer cell lines

Author(s)

ALIABADI ALIREZA | MOHAMMADI FARANI AHMAD | Haqiqi Arash | Khanlari Elham | Issue Writer Certificate

Keywords

AnticancerQ2

CytotoxicityQ2

NaphthalimideQ1

LipoxygenaseQ2

Abstract

Introduction: Cancer has been known as one the main causes of the death in the world. In recent researches, discovery of effective, selective and safe medications is a priority and emergency. In recent reports, the role of Lipoxygenases (LOX) has been confirmed in neoplastic diseases. Some isoenzymes such as 5, 12 and 15 have more importance in the neoplasia. According to the efficacy of Naphthalimides as LOX inhibitor, herein we explored the Cytotoxicity of Naphthalimide derivatives. Methods: A basic study was carried out in the current research. The Cytotoxicity of a new series of Naphthalimide-based 15-LOX-1 inhibitors was evaluated in three cancerous cell lines namely SKNMC (neuroblastoma), PC3 (prostatic cancer), HT29 (colorectal cancer) using MTT protocol and the obtained data was compared to doxorubicin. Calculation of the IC50 of tested compounds was performed by regression analysis using Prism-6 software. Results: Totally, all tested compounds exhibited inferior activity than doxorubicin towards HT-29, SKNMC and PC3 cell lines. SKNMC cell line rendered more sensitivity to tested compounds. Amongst the compounds 3a-3m, compound 3e (3-methoxy) and 3i (4-F) with IC50 = 5. 92± 1. 78 μ M and 10. 04± 1. 7 μ M were the most potent derivatives towards PC3 cells. Conclusion: Although all compounds did not exert more potency in comparison with doxorubicin, some of them showed remarkable Cytotoxicity. The potent derivatives could be introduced as novel lead compounds for development of new Anticancer drugs.

Cites

No record.

References

No record.

Cite

APA: Copy

ALIABADI, ALIREZA, MOHAMMADI FARANI, AHMAD, Haqiqi, Arash, & Khanlari, Elham. (2019). Cytotoxicity evaluation of a new series of naphthalimide derivatives against human cancer cell lines. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, 26(11 ), 998-1007. SID. https://sid.ir/paper/36309/en

Vancouver: Copy

ALIABADI ALIREZA, MOHAMMADI FARANI AHMAD, Haqiqi Arash, Khanlari Elham. Cytotoxicity evaluation of a new series of naphthalimide derivatives against human cancer cell lines. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2019;26(11 ):998-1007. Available from: https://sid.ir/paper/36309/en

IEEE: Copy

ALIREZA ALIABADI, AHMAD MOHAMMADI FARANI, Arash Haqiqi, and Elham Khanlari, “Cytotoxicity evaluation of a new series of naphthalimide derivatives against human cancer cell lines,” JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, vol. 26, no. 11 , pp. 998–1007, 2019, [Online]. Available: https://sid.ir/paper/36309/en

Related Journal Papers